Clinical Trials are conducted at VOSM in Annapolis Junction, MD. In order for an animal to participate in a clinical trial they must meet the general inclusion criteria and the specific qualifications for each study. To get involved with with any of the studies below, please contact Jeff Curry, research technician, at (240) 295-4400 or jcurry@vosm.com.

​

General Inclusion Criteria:

​

• Dog of any breed

• Between the ages of 2 and 12 years

• Minimum weight of 25 pounds

• Medically suitable for sedation or general anesthesia

• No history of malignancy

• Complete history and physical examination

​

Gelatin Scaffold

​

​

​

​

​

Gelatin Scaffold is an engineered collagen bioscaffold that has been reported to reduce the pain associated with osteoarthritis.  It is thought that Gelatin Scaffold works by providing a pathway for cell proliferation, differentiation, and integration that may help to improve cartilage repair and function in the location of the injection. It is created from a highly purified derivative of porcine collagen. Two promising pilot studies which included 14 dogs in total have already been performed at VOSM and we are currently seeking candidates for a larger crossover study.

​

Side effects from this clinical trial are unlikely but could include joint infection, pain post-injection, lack of clinical improvement of symptoms, and risks associated with sedation. Most patients are able to participate in this clinical trial without sedation, and discomfort (if present) typically subsides within a day or two of the injection.

 

Study qualifications are listed below.

• Dogs must weigh 40 - 100 lbs

• Dogs must have a diagnosis of elbow, shoulder, stifle or hip (osteo)arthritis

• Dogs must have history and be able to participate in a physical exam

• Dog must not have any medical conditions which will interferes with their ability to comply with the protocol or interpretation of study results (ex. neurological disease, hypothyroidism, diabetes, cancer, pregnancy.)

 

The length of this clinical trial is 180 days. Patients will have rechecks (~1 hour) scheduled for 14, 30, 60, 104, 120, 150, 180 days post enrollment.  This is a placebo controlled study; on day 0 ten patients will receive an injection of the product and 10 will only appear to have received an injection. On day 90 patients that did not receive an injection prior will receive an injection of the product; patients that received an injection on day 0 will only appear to have received an injection on day 90. Owners and doctors will not be unblinded until the end of the study unless it is required for patient health and safety. 

 

If you are interested in participating in the new clinical trial and helping us to make this product available in the future for other dogs suffering from arthritis please email Jeff Curry, jcurry@vosm.com.

​

Pending Publications

Tsoi H, Canapp SO, Canapp DA. Ultrasonographic detection of cranial cruciate ligament pathology in canine stifles without overt instability. Manuscript submitted for peer review

 

Tsoi H, Carr II JB, Canapp SO. The use of needle arthroscopy for the diagnosis and treatment of shoulder, elbow and stifle intra-articular pathologies in the canine. Manuscript submitted for peer review

 

Additional Projects

​

2020 - Present: Centre Hospitalier Vétérinaire Frégis – Arcueil, France Veterinary Orthopedic and Sports Medicine Group – Annapolis Junction, MD Advisor: Guillaume Ragetly, DVM, PhD, DACVS, DECVS

Project: Multicenter study on the arthroscopic management of osteochondritis dissecans lesions of the tibiotarsal joint in dogs.

Data collection in progress

 

2020 - Present: Veterinary Orthopedic and Sports Medicine Group – Annapolis Junction, MD Advisor: Sherman Canapp, DVM, MS, CCRT, DACVS, DACVSMR

Project: Injuries in sporting dogs.

Data collection in progress

 

2019 - Present: Veterinary Orthopedic and Sports Medicine Group – Annapolis Junction, MD Advisors: Sherman Canapp, DVM, MS, CCRT, DACVS, DACVSMR & Debra Canapp, DVM, CCRT, CVA, DACVSMR

Project: Incidence of medial and lateral collateral ligament pathologies in cranial cruciate ligament deficient stifles as detected on musculoskeletal ultrasound.

Data collection in progress.

 

 

​